Amy Ziminski
Gynecology · Sparta, NJNPI 1548892318
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $450 of the $514 with a category attached, or 87.5%. It is spread thinly across 10 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $165, 3.0 times the $55 reported in 2021.
Across 30 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$109
- AbbVie$84
- Exeltis, USA Inc.$82
- Organon$67
- Millicent US Inc$45
- Exact Sciences$34
- plus $93 from 4 others
What the payments were for
- Food & beverage$45088%
- Education$6412%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 5 | $109 |
| AbbVie | 6 | $84 |
| Exeltis, USA Inc. | 5 | $82 |
| Organon | 4 | $67 |
| Millicent US Inc | 1 | $45 |
| Exact Sciences | 1 | $34 |
| Mayne Pharma Commercial LLC | 4 | $29 |
| Bausch Health US, LLC | 2 | $28 |
| Pfizer | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $17 |
How this compares
$514 in reported general payments places this provider in the 55th percentile of 97 gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $2,387 |
| Alendronate Sodium | 17 | $138 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Sparta
- James TursiLumberton$217K
- Marco PelosiBayonne$164K
- Heather van RaaltePrinceton$140K
- Scott EderPrinceton$124K
- Michael VardyEnglewood$114K
- Daryl BoffardUnion$55K
- Shyama MathewsPlainsboro$54K
- Lora LiuJersey City$36K
- Mark EinsteinNewark$27K
- Jessica Opoku-AnaneNew Brunswick$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.